Condyloma

(redirected from condylomata acuminata)
Also found in: Dictionary, Thesaurus, Medical.
Related to condylomata acuminata: molluscum contagiosum

Condyloma

 

in man, a limited inflammatory papillate out-growth of the skin and mucosa.

Condylomas usually arise in places subject to constant friction and irritation. A distinction is made between flat condylomas, mushroomlike growths resting on a broad base that are generally a manifestation of secondary syphilis or yaws, and acuminate condylomas, which are caused by a virus, have a lobular structure, and rest on a thin pedicle.

Condylomas develop, as a rule, in slovenly persons on genitalia that have been moistened by excretions and irritated, in the intergluteal and inguinal folds, and less commonly, in the arm-pits and in the corners of the mouth. The surface of a condyloma may become ulcerated. Condylomas do not disappear spontaneously. They can be treated by eliminating the primary pathological process (treating the syphilis, gonorrhea, yaws, or intertrigo) or by electrocoagulation or curettage.

References in periodicals archive ?
Interferon alfa therapy is used as a frontline treatment for a number of indications including the treatment of malignant melanoma, hairy cell leukemia, chronic hepatitis B, chronic hepatitis C, condylomata acuminata, follicular (non-Hodgkin's) lymphoma, and AIDS-related Kaposi's sarcoma.
In addition to chronic hepatitis B, INTRON A is marketed in the United States for the treatment in adults of chronic hepatitis C, hairy cell leukemia, AIDS-related Kaposi's sarcoma, condylomata acuminata (venereal warts), and as adjuvant therapy for malignant melanoma and in combination with chemotherapy for non- Hodgkin's lymphoma.
In addition to non-Hodgkin's lymphoma, INTRON A has received marketing clearance in the United States for the treatment of chronic hepatitis B, chronic hepatitis C, hairy cell leukemia, AIDS-related Kaposi's sarcoma, condylomata acuminata (venereal warts) and as adjuvant therapy for malignant melanoma.
Schering-Plough markets INTRON A in the United States for six indications: hepatitis C, hepatitis B, hairy cell leukemia, AIDS-related Kaposi's sarcoma, condylomata acuminata (venereal warts) and as adjuvant therapy for malignant melanoma.